Figure 2. Effects of a selective leptin receptor antagonist on breast cancer stem cell activity.
MFE evaluated in MCF-7-M1 and MCF-7-M2 (A) and in MDA-MB-231-M1 and MDA-MB-231-M2 (B) treated with CAF-CM and Adipo-CM with/without peptide LDFI (1 μg/ml). The values represent the means ± s.d. of three different experiments each performed in triplicate. *p < 0.05.